ArticleApplied biochemistry and biotechnology2026
Citrus limon-Derived Extracellular Vesicles Promote Hair Growth.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of Exosomes (EXOs) to induce the regeneration of hair follicles has received much attention today. The present study was conducted to survey the effects of Citrus limon-derived EXOs (EXO-CLs) on promoting hair growth. EXOs were isolated from citrus limon by the filtration technique. According to NanoSight DynamicLight Scattering and Scanning Electron Microscopy, the extracted EXOs had a size of 147 nm and a spherical morphology. The flow cytometry analysis showed the expression of surface markers CD9 (64.6%), CD63(66.2%), and CD81(65.2%). The MTT test showed a significant increase in the percentage of human skin fibroblast cell viability in the group treated with EXO-CLs (400 µg/mL) compared to the control. The evaluations performed in vivo phase showed a significant increase in the thickness of dermis, the number of hair follicles, and the percentage of collagen were observed in the group treated with EXO compared to the negative control group. The expression ratio of Wnt-1, β-Catenin, Lef1, Vegf, Tgf-β1, and Collagen I genes respectively, increased by a factor of 4.4, 4.8, 2.7, 2.3, 4.6, and 2.4 in EXO-CLs groups compared to the negative control group. According to the findings, the EXO-CLs could promote hair follicle regeneration in vivo and improve hair regrowth.
Indexed as
Identifiers
42090071What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.